Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up

BACKGROUND: Heterogeneity of prostate cancer (PCa) contributes to inaccurate cancer screening and diagnosis, unnecessary biopsies, and overtreatment. We intended to develop non-invasive urine tests for accurate PCa diagnosis to avoid unnecessary biopsies. METHODS: Using a machine learning program, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Heather, Guo, Jinan, Zhang, Xuhui, Zhang, Heqiu, Simoulis, Athanasios, Wu, Alan H. B., Xia, Taolin, Li, Fei, Tan, Wanlong, Johnson, Allan, Dizeyi, Nishtman, Abrahamsson, Per-Anders, Kenner, Lukas, Feng, Xiaoyan, Zou, Chang, Xiao, Kefeng, Persson, Jenny L., Chen, Lingwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706045/
https://www.ncbi.nlm.nih.gov/pubmed/33256740
http://dx.doi.org/10.1186/s12916-020-01834-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706045/
https://www.ncbi.nlm.nih.gov/pubmed/33256740
http://dx.doi.org/10.1186/s12916-020-01834-0

Ejemplares similares